A national pilot of donation after circulatory death (DCD) heart transplantation within the United Kingdom.


Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
08 2023
Historique:
received: 17 11 2022
revised: 10 02 2023
accepted: 05 03 2023
medline: 7 8 2023
pubmed: 10 4 2023
entrez: 9 4 2023
Statut: ppublish

Résumé

The United Kingdom (UK) was one of the first countries to pioneer heart transplantation from donation after circulatory death (DCD) donors. To facilitate equity of access to DCD hearts by all UK heart transplant centers and expand the retrieval zone nationwide, a Joint Innovation Fund (JIF) pilot was provided by NHS Blood and Transplant (NHSBT) and NHS England (NHSE). The activity and outcomes of this national DCD heart pilot program are reported. This is a national multi-center, retrospective cohort study examining early outcomes of DCD heart transplants performed across 7 heart transplant centers, adult and pediatric, throughout the UK. Hearts were retrieved using the direct procurement and perfusion (DPP) technique by 3 specialist retrieval teams trained in ex-situ normothermic machine perfusion. Outcomes were compared against DCD heart transplants before the national pilot era and against contemporaneous donation after brain death (DBD) heart transplants, and analyzed using Kaplan-Meier analysis, chi-square test, and Wilcoxon's rank-sum. From September 7, 2020 to February 28, 2022, 215 potential DCD hearts were offered of which 98 (46%) were accepted and attended. There were 77 potential donors (36%) which proceeded to death within 2 hours, with 57 (27%) donor hearts successfully retrieved and perfused ex situ and 50 (23%) DCD hearts going on to be transplanted. During this same period, 179 DBD hearts were transplanted. Overall, there was no difference in the 30-day survival rate between DCD and DBD (94% vs 93%) or 90 day survival (90% vs 90%) respectively. There was a higher rate of ECMO use post-DCD heart transplants compared to DBD (40% vs 16%, p = 0.0006), and DCD hearts in the pre pilot era, (17%, p = 0.002). There was no difference in length of ICU stay (9 DCD vs 8 days DBD, p = 0.13) nor hospital stay (28 DCD vs 27 DBD days, p = 0.46). During this pilot study, 3 specialist retrieval teams were able to retrieve DCD hearts nationally for all 7 UK heart transplant centers. DCD donors increased overall heart transplantation in the UK by 28% with equivalent early posttransplant survival compared with DBD donors.

Sections du résumé

BACKGROUND
The United Kingdom (UK) was one of the first countries to pioneer heart transplantation from donation after circulatory death (DCD) donors. To facilitate equity of access to DCD hearts by all UK heart transplant centers and expand the retrieval zone nationwide, a Joint Innovation Fund (JIF) pilot was provided by NHS Blood and Transplant (NHSBT) and NHS England (NHSE). The activity and outcomes of this national DCD heart pilot program are reported.
METHODS
This is a national multi-center, retrospective cohort study examining early outcomes of DCD heart transplants performed across 7 heart transplant centers, adult and pediatric, throughout the UK. Hearts were retrieved using the direct procurement and perfusion (DPP) technique by 3 specialist retrieval teams trained in ex-situ normothermic machine perfusion. Outcomes were compared against DCD heart transplants before the national pilot era and against contemporaneous donation after brain death (DBD) heart transplants, and analyzed using Kaplan-Meier analysis, chi-square test, and Wilcoxon's rank-sum.
RESULTS
From September 7, 2020 to February 28, 2022, 215 potential DCD hearts were offered of which 98 (46%) were accepted and attended. There were 77 potential donors (36%) which proceeded to death within 2 hours, with 57 (27%) donor hearts successfully retrieved and perfused ex situ and 50 (23%) DCD hearts going on to be transplanted. During this same period, 179 DBD hearts were transplanted. Overall, there was no difference in the 30-day survival rate between DCD and DBD (94% vs 93%) or 90 day survival (90% vs 90%) respectively. There was a higher rate of ECMO use post-DCD heart transplants compared to DBD (40% vs 16%, p = 0.0006), and DCD hearts in the pre pilot era, (17%, p = 0.002). There was no difference in length of ICU stay (9 DCD vs 8 days DBD, p = 0.13) nor hospital stay (28 DCD vs 27 DBD days, p = 0.46).
CONCLUSION
During this pilot study, 3 specialist retrieval teams were able to retrieve DCD hearts nationally for all 7 UK heart transplant centers. DCD donors increased overall heart transplantation in the UK by 28% with equivalent early posttransplant survival compared with DBD donors.

Identifiants

pubmed: 37032222
pii: S1053-2498(23)01780-1
doi: 10.1016/j.healun.2023.03.006
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1120-1130

Informations de copyright

Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have no conflicts of interest to declare. This research was funded by the National Health Service Blood and Transplant and National Health Service England.

Auteurs

Simon Messer (S)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK; Golden Jubilee University National Hospital, Glasgow, Scotland.

Sally Rushton (S)

National Health Service Blood and Transplant, Bristol, UK.

Lewis Simmonds (L)

National Health Service Blood and Transplant, Bristol, UK.

Debbie Macklam (D)

National Health Service Blood and Transplant, Bristol, UK.

Mubbasher Husain (M)

Royal Brompton and Harefield Hospital, Harefield, Uxbridge, UK.

Anand Jothidasan (A)

Royal Brompton and Harefield Hospital, Harefield, Uxbridge, UK.

Stephen Large (S)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Steven Tsui (S)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Pradeep Kaul (P)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Jennifer Baxter (J)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Mohamed Osman (M)

Royal Brompton and Harefield Hospital, Harefield, Uxbridge, UK.

Vipin Mehta (V)

Wythenshawe Hospital, Manchester, UK.

Derval Russell (D)

Royal Brompton and Harefield Hospital, Harefield, Uxbridge, UK.

Uli Stock (U)

Royal Brompton and Harefield Hospital, Harefield, Uxbridge, UK.

John Dunning (J)

Royal Brompton and Harefield Hospital, Harefield, Uxbridge, UK.

Diana Garcia Saez (DG)

Royal Brompton and Harefield Hospital, Harefield, Uxbridge, UK.

Rajamiyer Venkateswaran (R)

Wythenshawe Hospital, Manchester, UK.

Philip Curry (P)

Golden Jubilee University National Hospital, Glasgow, Scotland.

Lynne Ayton (L)

Golden Jubilee University National Hospital, Glasgow, Scotland.

Majid Mukadam (M)

Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Jorge Mascaro (J)

Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Jacob Simmonds (J)

Great Ormond Street Hospital for Children, London, UK.

Guy Macgowan (G)

Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.

Stephen Clark (S)

Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.

Jerome Jungschleger (J)

Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.

Zdenka Reinhardt (Z)

Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.

Richard Quigley (R)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Jane Speed (J)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Jayan Parameshwar (J)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

David Jenkins (D)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Sarah Watson (S)

National Health Service England, Highly Specialised Services, London, UK.

Fiona Marley (F)

National Health Service England, Highly Specialised Services, London, UK.

Ayesha Ali (A)

National Health Service England, Highly Specialised Services, London, UK.

Dale Gardiner (D)

National Health Service Blood and Transplant, Bristol, UK.

Antonio Rubino (A)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK; National Health Service Blood and Transplant, Bristol, UK.

Julie Whitney (J)

National Health Service Blood and Transplant, Bristol, UK.

Sarah Beale (S)

National Health Service Blood and Transplant, Bristol, UK.

Catherine Slater (C)

National Health Service Blood and Transplant, Bristol, UK.

Ian Currie (I)

National Health Service Blood and Transplant, Bristol, UK.

Liz Armstrong (L)

National Health Service Blood and Transplant, Bristol, UK.

Jeanette Foley (J)

National Health Service Blood and Transplant, Bristol, UK.

Marian Ryan (M)

National Health Service Blood and Transplant, Bristol, UK.

Sharon Gibson (S)

National Health Service Blood and Transplant, Bristol, UK.

Karen Quinn (K)

National Health Service Blood and Transplant, Bristol, UK.

Anna-Maria Macleod (AM)

NHS Scotland, Edinburgh, Scotland.

Susan Spence (S)

NHS Wales, Cardiff, UK.

Christopher J E Watson (CJE)

National Health Service Blood and Transplant, Bristol, UK.

Pedro Catarino (P)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.

Anthony Clarkson (A)

National Health Service Blood and Transplant, Bristol, UK.

John Forsythe (J)

National Health Service Blood and Transplant, Bristol, UK.

Derek Manas (D)

National Health Service Blood and Transplant, Bristol, UK.

Marius Berman (M)

Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK; National Health Service Blood and Transplant, Bristol, UK. Electronic address: marius.berman@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH